The Nikkei 225 fell for a third straight session on the 9th, closing in the ¥69,030 range after recovering in the afternoon. JCR Pharma surged after a securities firm raised its investment rating.
The Nikkei 225 continued to decline from the opening on the 9th, ending at ¥69,030.92, down ¥11.19 from the previous day. In the morning session, heavy selling of U.S. technology stocks weighed on the market, and the index opened nearly ¥400 lower.
Trading value on the TSE Prime Market was approximately ¥7.84 trillion. Marine transportation, other products and services rose by sector, while banks, nonferrous metals and retail declined. JCR Pharma surged after a securities firm raised its investment rating.
Asahi Kasei, meanwhile, fell sharply after a securities firm downgraded its investment rating. TOPIX rose, while trading volume was 2.29 billion shares and trading value was ¥7.84 trillion.
Futures were firm at 69,470, up 370, and the growth stock index edged higher. Across the market, some stocks, including AI-related names, turned positive.